Skip to main content
Show full summary

Lord Blencathra to ask Her Majesty's Government why Fampridine is authorised for general NHS use in (1) Scotland, and (2) Wales, but is not permitted for new patients in England.  HL6177

Question HL6177: tabled on 10 February 2022 and due for answer by 24 February 2022

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Blencathra to ask Her Majesty's Government why Fampridine is authorised for general NHS use in (1) Scotland, and (2) Wales, but is not permitted for new patients in England.  HL6177
Legend for business item text
Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.